Amoxicillin Clavulanate Articles
GlaxoSmithKline sells US penicillin facility and products to India’s Dr Reddy’s; GSK favored in Paxil trial
24 November 2010
Philippines seeks more voluntary drug price reductions
19 January 2010
GlaxoSmithKline beats forecasts with 3rd quarter2009 profits leaping 34%, despite generic competition
28 October 2009
Headlines 25 years ago this week....
5 November 2007
Headlines 25 years ago this week....
5 June 2006
Generic approvals for Mylan and Teva
21 February 2005
GSK initiates Phase III trials of key drug using Flamel's Micropump
27 September 2004
GSK settles US Augmentin antitrust litigation
19 July 2004
GSK results in line with company guidance; shares fall on 16% drop in 4th-qtr income
23 February 2004
GSK drops Flamel augmentin deal
27 October 2003
GSK 2nd-qtr earnings beat forecasts
28 July 2003
Novartis and GSK settle on Augmentin
21 July 2003
Ranbaxy revises target on US sales
14 July 2003
Novartis/GSK Augmentin dispute will now go to trial
23 June 2003
Stock Commentary - Europe
21 April 2003
New Augmentin generic for Ranbaxy
31 March 2003
IVAX seeks approval for generic Flonase
17 March 2003
Earnings up at Teva on strong generic sales
24 February 2003
Update: GSK 2002 results boosted by 13% growth in US sales
17 February 2003
GlaxoSmithKline 2002 results boosted by 13% growth in US sales
17 February 2003
Lek takes on GSK's Augmentin in USA
13 January 2003
Aventis wins advisory panel backing for multiple Ketek claims
13 January 2003
Stock Commentary - Europe
29 July 2002
GSK to sue over generic Augmentin launch?
22 July 2002
Geneva says its generic Augmentin is USA's first
22 July 2002
GSK licenses Micropump
15 July 2002
Stock Commentary - Europe
10 June 2002
Stock Commentary - Europe
3 June 2002
Ad firm defends the pharma industry
29 April 2002
Stock Commentary - Europe
25 March 2002
GSK to appeal bupropion ruling
11 March 2002
GlaxoSmithKline 2001 pretax exceeds forecasts
18 February 2002
Broker views outlook for GSK's Augmentin court case
11 February 2002
Zithromax approved by FDA for new otitis media regimen
7 January 2002
Teva has final FDA OK for generic Mevacor
7 January 2002
US court rules against GSK on Augmentin patent
7 January 2002
Teva has final FDA OK for generic Mevacor
19 December 2001
Zithromax approved by FDA for new otitis media regimen
18 December 2001
US court rules against GSK on augmentin patent
17 December 2001
Pfizer's one-day Zithromax course squeaks through FDA advisory panel
12 November 2001
French price cuts for GSK, Lilly, Merck drugs
16 August 2001
Novartis unit taking on GSK over patents
12 June 2001
GSK restructuring its R&D to boost productivity
22 February 2001
GlaxoSmithKline starts life in 2001 on a strong financial footing
21 February 2001
FDA panel reviews LYMErix safety
1 February 2001
India's Ranbaxy eyes French generics mart
12 January 2001
W-A's Premarin is top US formulary drug
29 November 2000
Strong earnings growth for Glaxo Wellcome and SmithKline Beecham
1 November 2000
Stock Commentary Europe
9 March 2000
Glaxo SmithKline, an R&D powerhouse and global number one
17 January 2000
SmithKline Beecham files for US approval of new quinolone
16 December 1999
SB sales increase 11% boosted by Avandia
21 July 1999
Currency impact lifts SmithKline Beecham
20 April 1999
New US CDC otitis media treatment guidelines
26 January 1999
Pioglitazone; Competition For Rezulin/Avandia?
26 November 1998
New Augmentin Form For Otitis Media
20 October 1998
Solid Third Quarter At SB Thanks To New Products
20 October 1998
New Antibacterials Showcased At ICAAC
14 October 1998
SmithKline Beecham Expanding In Romania
29 September 1998
Currency And Flu Factors Hold Back SB Results
22 July 1998
USA's Most-Dispensed Rx Drugs In April 1998
20 May 1998
SB's 1st-Quarter Impacted Again By Strong Sterling
22 April 1998
Currency Hits SmithKline Beecham Sales And Profits
17 February 1998
Biaxin As Effective As Co-Amoxiclav In Bronchitis
11 February 1998
GW-SB Merger Will Create R&D Superpower
5 February 1998
Strong Sterling Hits 3rd Qtr Profits At SB
22 October 1997
Greek Govt Adjusts Prices Of 6,009 Drugs
3 October 1997
GW's Zantac Knocked Off Top US Rx Drug Spot
4 September 1997
Clinton Plans New Rules On Child Drug Safety
19 August 1997
Strong Sterling Impacts SmithKline Beecham
23 July 1997
Glaxo Wellcome's Promising New Antibiotic
10 July 1997
SB And G-b Settle Augmentin Dispute
19 May 1997
Underlying Strength In 1st Qtr At SmithKline Beecham
23 April 1997
Astra's Losec "World's No One Drug In 1998-2000"
16 December 1996
SmithKline Beecham Fights French Generics
14 October 1996
Tactical Diversity In The Evolving US Health Market
17 June 1996
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
